Patients with insulin episodes of effective diabetes enjoy affordable
Author:Jining Daily Time:2022.09.26
(Reporter Wan Delong) "Originally buying an insulin need 180 yuan, now it only costs 70 yuan. It can save 4,000 yuan in a year. Thank you for such a good policy." Aunt Wang, a diabetic patient, said.
In May this year, the public medical institutions of Jiaxiang County officially implemented the sixth batch of national collection (insulin special) selection results. The special collection covers the second -generation and third -generation insulin commonly used in clinical collection. 73%. As of September 20, 15 public medical institutions in the county have purchased a total of 20133 insulin, with a purchase fee of 906161.67 yuan. In just over 3 months, the cumulative purchase volume was basically the same compared with the same period last year, but the purchase of procurement The cost was reduced by 1 million yuan, which greatly reduced the cost of seeking medical treatment for patients and further reduced the burden of medical treatment of patients with diabetes.
In the next step, the Jiaxiang County Medical Insurance Bureau will carry out the requirements for the purchase of drug concentrated band in accordance with the normalized institutionalization. Procurement and medical insurance payment standards are coordinated, allowing the country's tissue to procure bonuses to implement it, and allow the masses to enjoy more high -quality and affordable pharmaceutical services.
- END -
When you travel, you are bitten by a snake, do not suck with your mouth!Chinese medicine reminder: Use these Chinese herbal medicines to rescue urgency
After entering the summer vacation, more and more people take their children to go...
my country's new medicine research and development reached a record high, and how the innovative results have been achieved?
The 2021 review passed 47 innovative medicines--The research and development of new drugs hit a record high and how the innovation results areThe 2021 review passed the 47 innovative drugs, and hit a